Adderall XR Class Action Settlement
Class Eligibility
You are a member of this settlement if you are a U.S. resident who bought Adderall XR (brand name) between Jan. 1, 2007 and Apr. 11, 2016 for personal or household use within the following states: Alabama, Arizona, California, Delaware, Florida, Georgia, Idaho, Illinois, Iowa, Kansas, Maine, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Utah, Vermont, West Virginia, Wisconsin, as well as the District of Columbia.
Estimated Amount
Up to $16 per prescription
The total amount will vary based on the number of valid claims
Proof of Purchase
No
Case Name
Barba v. Shire U.S. Inc.,Case No. 1:13-cv-21158District Court for the Southern District of Florida
Case Summary
According to the documents in the lawsuit the defendant filed “sham patent litigations” against generic competitors of Adderall XR they also created a “sham Citizen Petition” with the U.S. Food and Drug Administration resulting in significant delays in the release of generic and more affordable versions
The defendant continues to deny allegations but has agreed to settle the class action to avoid the cost and risk of going to trial.
Settlement Pool
$14,750,000
Settlement Website
Deadline
10/07/2016
Contact
Barba v. Shire U.S., Inc. Settlement Administrator
c/o KCC, LLC
P.O. Box 40007
College Station, TX 77842-4007
877-369-4085
info@AdderallXRSettlement.com
According to the Class Action Administrator the checks were sent on 1/12/2018
